An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition
Clinical trial NCT07019194 · COMPLETED
Trial details
- NCT number
- NCT07019194
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-21
- Primary completion
- 2024-07-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.